Chong Kun Dang's Prigrel excluded from insurance list

Published: 2007-10-08 07:00:00

Updated: 2007-10-08 07:00:00

The National Health Insurance Corporation said on October 2 that it would not list Chong Kun Dang's Prigrel (clopidogrel resignate) into the positive list as the drug's superior efficacy over price cannot be found, when compared to the existing generic drugs of Plavix (clopidogrel bisulfate).

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK